AIM
MRNS

Alambic Investment Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Alambic Investment Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,566
Closed -$48K – 285
2019
Q4 		$48K Buy
+5,566
New +$31.2K 0.04% 268
2019
Q1 		– Sell
-9,200
Closed -$106K – 405
2018
Q4 		$106K Buy
+9,200
New +$186K 0.04% 276

Other funds holding MRNS

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Alambic Investment Management's MRNS Position: Q1 2020 in Review

Alambic Investment Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2020, closing a stake of 5,566 shares — an estimated $48K sold.

Alambic Investment Management first reported a position in MRNS in Q4 2018 and held it in 2 quarters. The position peaked at $106K in Q4 2018. 74 funds tracked by Wall St. Rank hold MRNS as of Q1 2020.

  • Alambic Investment Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2020 after selling out during the quarter.
  • Alambic Investment Management sold 5,566 Marinus Pharmaceuticals, Inc shares in Q1 2020, an estimated $48K.
  • Alambic Investment Management first reported a position in Marinus Pharmaceuticals, Inc in Q4 2018 and held it in 2 quarters.
  • Alambic Investment Management's Marinus Pharmaceuticals, Inc position peaked at $106K in Q4 2018.
  • 74 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2020.

Based on Alambic Investment Management's 13F filing for Q1 2020, filed 11 May 2020.